Royal Bank of Canada’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-35,076
| Closed | -$707K | – | 7545 |
|
|
2021
Q3 | $707K | Sell |
35,076
-6,864
| -16% | -$138K | ﹤0.01% | 3565 |
|
|
2021
Q2 | $1.57M | Buy |
41,940
+1,168
| +3% | +$43.6K | ﹤0.01% | 2906 |
|
|
2021
Q1 | $1.04M | Buy |
40,772
+40,657
| +35,354% | +$1.04M | ﹤0.01% | 3129 |
|
|
2020
Q4 | $3K | Sell |
115
-919
| -89% | -$24K | ﹤0.01% | 6275 |
|
|
2020
Q3 | $19K | Sell |
1,034
-200
| -16% | -$3.68K | ﹤0.01% | 5237 |
|
|
2020
Q2 | $31K | Buy |
1,234
+955
| +342% | +$24K | ﹤0.01% | 4954 |
|
|
2020
Q1 | $6K | Sell |
279
-2,356
| -89% | -$50.7K | ﹤0.01% | 5506 |
|
|
2019
Q4 | $58K | Buy |
+2,635
| New | +$58K | ﹤0.01% | 4798 |
|
|
2018
Q4 | – | Sell |
-1,192
| Closed | -$18K | – | 6310 |
|
|
2018
Q3 | $18K | Buy |
1,192
+1,039
| +679% | +$15.7K | ﹤0.01% | 5139 |
|
|
2018
Q2 | $2K | Buy |
+153
| New | +$2K | ﹤0.01% | 5707 |
|
|
2018
Q1 | – | Sell |
-1,016
| Closed | -$9K | – | 6133 |
|
|
2017
Q4 | $9K | Buy |
1,016
+1,007
| +11,189% | +$8.92K | ﹤0.01% | 5167 |
|
|
2017
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 6223 |
|
|
2016
Q1 | – | Sell |
-22
| Closed | – | – | 5859 |
|
|
2015
Q4 | $0 | Sell |
22
-700
| -97% | – | ﹤0.01% | 6080 |
|
|
2015
Q3 | $6K | Sell |
722
-248
| -26% | -$2.06K | ﹤0.01% | 5517 |
|
|
2015
Q2 | $14K | Buy |
+970
| New | +$14K | ﹤0.01% | 5411 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | – | – | 5832 |
|
|
2014
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 5687 |
|